BB BIOTECH AG 13D and 13G filings for Sage Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-17 06:02 am Sale |
2025-01-13 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 1,178,503 1.900% |
-3,282,190 (-73.58%) |
Filing |
| 2024-11-14 6:14 pm Purchase |
2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 4,460,693 7.300% |
955,693 (+27.27%) |
Filing |
| 2024-02-13 06:28 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 3,505,000 5.800% |
404,722 (+13.05%) |
Filing |
| 2023-02-17 5:23 pm Purchase |
2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 3,100,278 5.200% |
150,000 (+5.08%) |
Filing |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 2,950,278 5.000% |
-219,826 (-6.93%) |
Filing |
| 2022-02-11 4:36 pm Purchase |
2021-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 3,170,104 5.400% |
210,000 (+7.09%) |
Filing |
| 2021-08-11 5:04 pm Purchase |
2021-08-04 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 2,960,104 5.000% |
2,960,104 (New Position) |
Filing |